Literature DB >> 9649259

Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men.

C S Cooper1, P J Perry, A E Sparks, J H MacIndoe, W R Yates, R D Williams.   

Abstract

PURPOSE: We investigate and define the effects of exogenous testosterone on the normal prostate.
MATERIALS AND METHODS: A total of 31 healthy volunteers 21 to 39 years old were randomized to receive either 100, 250 or 500 mg. testosterone via intramuscular injection once a week for 15 weeks. Baseline measurements of serum testosterone, free testosterone and prostate specific antigen (PSA) were taken at week 1. Semen samples were also collected for PSA content and prostate volumes were determined by transrectal ultrasound before testosterone injection. Blood was then drawn every other week before each testosterone injection for the 15 weeks, every other week thereafter until week 28 and again at week 40. After the first 15 weeks semen samples were again collected, and prostate volumes were determined by repeat transrectal ultrasound.
RESULTS: Free and total serum testosterone levels increased significantly in the 250 and 500 mg. dose groups. No significant change occurred in the prostate volume or serum PSA levels at any dose of exogenous testosterone. Total semen PSA levels decreased following administration of testosterone but did not reach statistical significance.
CONCLUSIONS: Despite significant elevations in serum total and free testosterone, healthy young men do not demonstrate increased serum or semen PSA levels, or increased prostate volume in response to exogenous testosterone injections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649259     DOI: 10.1016/s0022-5347(01)63944-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Differing levels of testosterone and the prostate: a physiological interplay.

Authors:  S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

Review 2.  Male hormonal contraception: potential risks and benefits.

Authors:  Niloufar Ilani; Ronald S Swerdloff; Christina Wang
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

Review 3.  Testosterone Therapy Among Prostate Cancer Survivors.

Authors:  Taylor M Nguyen; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-07-27

Review 4.  Testosterone Therapy in Men With Prostate Cancer.

Authors:  Alan L Kaplan; Jim C Hu; Abraham Morgentaler; John P Mulhall; Claude C Schulman; Francesco Montorsi
Journal:  Eur Urol       Date:  2015-12-21       Impact factor: 20.096

5.  Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.

Authors:  Yasuhito Funahashi; Zhou Wang; Katherine J O'Malley; Pradeep Tyagi; Donald B DeFranco; Jeffrey R Gingrich; Ryosuke Takahashi; Tsuyoshi Majima; Momokazu Gotoh; Naoki Yoshimura
Journal:  Prostate       Date:  2014-11-28       Impact factor: 4.104

Review 6.  Hypogonadism and its treatment among prostate cancer survivors.

Authors:  Edward J Choi; Perry Xu; Farouk M El-Khatib; Linda M Huynh; Faysal A Yafi
Journal:  Int J Impot Res       Date:  2020-12-12       Impact factor: 2.896

7.  Androgen replacement therapy after prostate cancer treatment.

Authors:  Mohit Khera
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 8.  Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?

Authors:  Wesley Baas; Tobias S Köhler
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

Review 9.  Androgen therapy in the aging male.

Authors:  Bruno Lunenfeld
Journal:  World J Urol       Date:  2003-10-24       Impact factor: 4.226

Review 10.  Testosterone therapy and prostate carcinoma.

Authors:  Ernani Luis Rhoden; Márcio Augusto Averbeck
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.